Read More
Read more about treatment-resistant depression here.
First US TRD Awareness Day spotlights treatment-resistant depression, urging earlier recognition, stigma-breaking support, and renewed hope for patients and caregivers.
Today, October 14, 2026, is the first-ever Treatment-Resistant Depression (TRD) Awareness Day in the US. This day is dedicated to recognizing and advocating for individuals, caregivers, and communities who are impacted by TRD. The campaign is a joint effort between Compass Pathways and leading mental health organizations, including National Alliance on Mental Illness (NAMI), Mental Health America, and the Depression and Bipolar Support Alliance (DBSA).1
According to Compass’ release, TRD affects approximately 4 million individuals in the US, with fewer than 5% currently receiving TRD-indicated treatment.1 TRD Awareness Day was established to increase understanding of this condition, help people recognize its signs earlier, and encourage conversations about finding support.
Read more about treatment-resistant depression here.
“People living with [TRD] deserve to know that their experiences are recognized, their voices matter and there are people working alongside them to drive meaningful change,” said Steve Levine, MD, chief patient officer at Compass Pathways. “At Compass, we are deeply committed to the TRD community and to elevating the experiences of patients and caregivers as we work to address the significant unmet needs that remain. By bringing greater awareness to TRD, we can help build a future where people facing this condition feel understood, better supported and more hopeful about what may be possible.”
A new survey found that nearly 95% of those living with TRD describe themselves as functioning but struggling, surviving day-to-day, or barely getting by. Additionally, nearly 2 in 3 caregivers say TRD impacts the whole family's social, physical, and/or mental health; more than half report that caregiving has taken a major toll on their own mental health.2 These results demonstrate that the burden of TRD extends beyond the individual and also directly affects caregivers and loved ones. The full report will be shared at a later date.
“For too many people living with TRD, the daily challenges of the condition are compounded by feeling misunderstood, judged or even blamed when treatments don’t work,” said Leah Wentworth, PhD, NAMI’s national director of science and research. “TRD’s impact extends to their families and caregivers as they help their loved ones navigate the condition. As we recognize the first TRD Awareness Day, we have an important opportunity to bring greater visibility to this community, challenge the stigma and misunderstanding surrounding TRD, and remind those affected that they are not alone.”
“When depression continues despite multiple treatment attempts, many people do not realize they may be experiencing TRD,” said Sagar V.Parikh, MD, FRCPC, the DBSA Scientific Advisory Board Vice Chair. “TRD Awareness Day can help both patients and clinicians better understand that this is a distinct condition, separate from major depressive disorder and recognize when it may be time to ask different questions about care strategies. Greater awareness is an important step towards helping people find the support they need and deserve.”
References
1. Compass Pathways joins forces with leading mental health organizations to mark first-ever U.S. Treatment-Resistant Depression (TRD) Awareness Day. News release. October 14, 2026. Accessed October 14, 2026.
2. Survey of Patients and Caregivers Living with Treatment-Resistant Depression. Compass Pathways. Data on file. 2026.



